Zio ECG Utilization Software (ZEUS) System vs Study Watch

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Verily

AI Verdict

The Zio ECG Utilization Software (ZEUS) System is primarily designed for clinical diagnosis and management of cardiac arrhythmias, offering AI-powered analysis of continuous ECG data for patient care. Conversely, the Verily Study Watch serves as a prescription-only wearable for continuous physiological monitoring specifically within clinical research settings. While both leverage wearables and cloud-based AI for cardiac data, their distinct focus on clinical diagnosis versus research makes them adjacent rather than direct competitors.

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if your primary objective is the clinical diagnosis and ongoing management of cardiac arrhythmias in patients. This AI-powered, cloud-based platform is ideal for physicians needing comprehensive, deep-learned ECG analysis from continuous wearable monitoring to inform treatment decisions and integrate with existing EHR systems.

View Zio ECG Utilization Software (ZEUS) System →

Choose Study Watch if…

Choose the Verily Study Watch if you are conducting clinical research that requires continuous, multi-modal physiological data collection from study participants. This prescription-only wearable is specifically designed for research settings, offering diverse data points like ECG, heart rate, and movement over an extended period for in-depth analysis within a secure cloud platform.

View Study Watch →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio ECG Utilization Software (ZEUS) System Study Watch
Deployment Cloud-based. The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub).
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio ECG Utilization Software (ZEUS) System

Tool A offers a comprehensive ecosystem with a dedicated web portal (ZioSuite) and mobile application for healthcare professionals, designed for ease of use in managing patients and interpreting diagnostic reports. Its patient-centric monitor design also promotes high compliance and comfortable wear, contributing to a smoother overall user experience for both clinicians and patients in a diagnostic setting.

Clinical Value

Zio ECG Utilization Software (ZEUS) System

Tool A is explicitly designed and clinically validated for aiding physicians in the diagnosis and management of cardiac arrhythmias, demonstrating superior diagnostic yield and improved patient outcomes in multiple large-scale studies compared to traditional monitoring. While Tool B collects valuable physiological data and has FDA clearance for ECG, its primary stated application is clinical research, with less direct evidence of immediate clinical utility for routine diagnostic care.

Pricing & Value

Zio ECG Utilization Software (ZEUS) System

While both tools lack publicly available pricing, Tool A has established Category I CPT codes for reimbursement, indicating a clear pathway for billing and demonstrating health-economic value through reduced retesting and healthcare expenditures in clinical settings. Tool B's pricing is tied to clinical research and partnerships, lacking a direct, transparent value proposition for routine clinical care reimbursement.

Enterprise Readiness

Zio ECG Utilization Software (ZEUS) System

Tool A demonstrates strong enterprise readiness with proven, seamless HL7-based EHR integration across major systems, including Epic, and a clear track record of HIPAA compliance and BAA handling. While Tool B also offers cloud deployment and adherence to security standards, the ongoing lawsuit alleging HIPAA violations and data misuse, despite Verily's denials, presents a significant potential risk and concern for enterprise partners.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. Tool A excels with its FDA-cleared, deep-learned AI algorithm for highly accurate cardiac arrhythmia detection and diagnosis over extended periods, leveraging a vast dataset. Tool B innovates through its multi-sensor physiological monitoring capabilities, robust device design for clinical research, and strategic partnerships to integrate diverse wearable data for comprehensive health insights in research.

Support & Docs

Zio ECG Utilization Software (ZEUS) System

Tool A provides clear and accessible support for healthcare professionals, including 24/7 customer care for clinical and billing inquiries, a dedicated clinical resource center with extensive documentation, and patient-facing resources. Tool B, being primarily for clinical research and partnerships, does not publicly detail a comparable level of direct support and documentation for a broad user base.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio ECG Utilization Software (ZEUS) System Study Watch
Product Name Zio ECG Utilization Software (ZEUS) System Study Watch
Company iRhythm Technologies Verily Life Sciences
Primary Purpose Analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research.
Core Data Analysis Method AI algorithm for arrhythmia detection and classification; proprietary deep-learned algorithms Algorithms and machine learning
Maximum Continuous Monitoring/Battery Life Up to 14 days (continuous ECG data analysis) Up to one week (long battery life)
EHR Integration HL7-based EHR integration Not specified

Videos

Demos, reviews, and walkthroughs featuring Zio ECG Utilization Software (ZEUS) System and Study Watch.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio ECG Utilization Software (ZEUS) System is designed to aid physicians in the diagnosis and management of cardiac arrhythmias. In contrast, the Verily Study Watch is a prescription-only device primarily for non-invasive, continuous physiological monitoring in clinical research.
The ZEUS System analyzes continuous ECG data from wearable Zio monitors. The Verily Study Watch collects data from multiple physiological sensors, including ECG, heart rate, electrodermal activity, and inertial movements.
The ZEUS System provides comprehensive end-of-wear reports for physician review through its ZioSuite web portal and mobile application. The Verily Study Watch uploads collected data from the device to Verily's cloud platform for processing with algorithms and machine learning.
The ZEUS System features HL7-based EHR integration. The provided information for the Verily Study Watch does not explicitly mention EHR integration.
The ZEUS System is capable of continuous ECG data analysis for up to 14 days. The Verily Study Watch offers a long battery life, supporting continuous monitoring for up to one week.
The ZEUS System is applicable to Cardiology, Family Medicine, and Internal Medicine. The Verily Study Watch is relevant for Cardiology, Neurology, and Sleep Medicine.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.